FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Layfield

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
Tao Wright; Andrew J Bennett; Ian M Copple; Christopher E Goldring; Alice Goode; Jed E Long; B Kevin Park; Thomas Ratajczak; Sarah L Rea; Mark S Searle; Robert Layfield
The S349T mutation of SQSTM1 links Keap1/Nrf2 signalling to Paget's disease of bone.
Nicolas Galazis; Zeina Haoula; Robert Layfield; Olalekan Olaleye; William Atiomo
Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration.
Kleitos Sokratous; Joanna Strachan; Robert Layfield; Lucy V Roach; Neil J Oldham
Cyclisation of Lys48-linked diubiquitin in vitro and in vivo.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Layfield (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Tao Wright; Andrew J Bennett; Ian M Copple; Christopher E Goldring; Alice Goode; Jed E Long; B Kevin Park; Thomas Ratajczak; Sarah L Rea; Mark S Searle; Robert Layfield
The S349T mutation of SQSTM1 links Keap1/Nrf2 signalling to Paget's disease of bone.
Bone 2013;52(2):699-706.
2012: Nicolas Galazis; Zeina Haoula; Robert Layfield; Olalekan Olaleye; William Atiomo
Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration.
Fertility and sterility 2012;98(6):1590-601.e1.
2012: Kleitos Sokratous; Joanna Strachan; Robert Layfield; Lucy V Roach; Neil J Oldham
Cyclisation of Lys48-linked diubiquitin in vitro and in vivo.
FEBS letters 2012;586(23):4144-7.
2012: Jonathan T S Hopper; Robert Layfield; José P Afonso; Deborah Channing; Andrew Rawlings; Neil J Oldham
Evidence for the preservation of native inter- and intra-molecular hydrogen bonds in the desolvated FK-binding protein·FK506 complex produced by electrospray ionization.
Journal of the American Society for Mass Spectrometry 2012;23(10):1757-67.
2012: Michael J Ingleson; Robert Layfield
N-Heterocyclic carbene chemistry of iron: fundamentals and applications.
Chemical communications (Cambridge, England) 2012;48(30):3579-89.
2012: Kleitos Sokratous; Joanna Strachan; Lucy V Roach; Mark S Searle; Debora Channing; Robert Layfield; Jed Long; Neil J Oldham
Probing affinity and ubiquitin linkage selectivity of ubiquitin-binding domains using mass spectrometry.
Journal of the American Chemical Society 2012;134(14):6416-24.
2012: Mark S Searle; Barry Shaw; Joanna Strachan; Jed Long; Jennifer Adlington; James R Cavey; Thomas P Garner; Robert Layfield
Structural insights into specificity and diversity in mechanisms of ubiquitin recognition by ubiquitin-binding domains.
Biochemical Society transactions 2012;40(2):404-8.
2012: L Chadwick; L Gentle; J Strachan; Robert Layfield
Review: unchained maladie - a reassessment of the role of Ubb(+1) -capped polyubiquitin chains in Alzheimer's disease.
Neuropathology and applied neurobiology 2012;38(2):118-31.
2012: Joanna Strachan; David Tooth; Thomas P Garner; Jed Long; Neil J Oldham; Lucy Roach; Mark S Searle; Kleitos Sokratous; Robert Layfield
Insights into the molecular composition of endogenous unanchored polyubiquitin chains.
Journal of proteome research 2012;11(3):1969-80.
2012: David John Tooth; Varun Gopala Krishna; Robert Layfield
An economical high-throughput protocol for multidimensional fractionation of proteins.
International journal of proteomics 2012;2012():735132.
2011: Daniel Woodruff; Michael Bodensteiner; Daniel O Sells; Richard E P Winpenny; Robert Layfield
Synthesis and structure of cationic guanidinate-bridged bimetallic {Li7M} cubes (M = Mn, Co, Zn) with inverse crown counter anions.
Dalton transactions (Cambridge, England : 2003) 2011;40(41):10918-23.
2011: James M Dorrian; Robert Layfield; Michael L Ridley; Deborah A Briggs; Ian D Kerr
Induction of a stress response in Lactococcus lactis is associated with a resistance to ribosomally active antibiotics.
The FEBS journal 2011;278(21):4015-24.
2011: Thomas P Garner; Robert Layfield; Jed E Long; Barry Shaw; Elizabeth C Shedden; Joanna Strachan; James R Cavey; Mark S Searle
Independent interactions of ubiquitin-binding domains in a ubiquitin-mediated ternary complex.
Biochemistry 2011;50(42):9076-87.
2011: Robert Layfield; Joseph J W McDouall; Manfred Scheer; Christoph Schwarzmaier; Floriana Tuna
Structure and bonding in three-coordinate N-heterocyclic carbene adducts of iron(II) bis(trimethylsilyl)amide.
Chemical communications (Cambridge, England) 2011;47(38):10623-5.
2011: Scott A Sulway; Michael Bodensteiner; Robert Layfield; Manfred Scheer; Sabine Scheuermayer; Manfred Zabel
Benzotriazolate cage complexes of tin(II) and lithium: halide-influenced serendipitous assembly.
Dalton transactions (Cambridge, England : 2003) 2011;40(29):7559-63.
2011: Anna Daroszewska; Euphemie Landao-Basonga; Robert Layfield; Javier A Rojas; Ken Rose; Lorraine Rose; Robert J van 't Hof; Stuart H Ralston
A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice.
Human molecular genetics 2011;20(14):2734-44.
2011: Sophia A Solomon; F Matthias Bickelhaupt; Robert Layfield; Mathias Nilsson; Jordi Poater; Miquel Solà
A donor-functionalized, silyl-substituted pentadienyllithium: structural insight from experiment and theory.
Chemical communications (Cambridge, England) 2011;47(21):6162-4.
2011: Thomas P Garner; Jed Long; Robert Layfield; Mark S Searle
Impact of p62/SQSTM1 UBA domain mutations linked to Paget's disease of bone on ubiquitin recognition.
Biochemistry 2011;50(21):4665-74.
2011: Scott A Sulway; David Collison; Joseph J W McDouall; Floriana Tuna; Robert Layfield
Iron(II) cage complexes of N-heterocyclic amide and bis(trimethylsilyl)amide ligands: synthesis, structure, and magnetic properties.
Inorganic chemistry 2011;50(6):2521-6.
2011: Lynn Bedford; Robert Layfield; R John Mayer; Junmin Peng; Ping Xu
Diverse polyubiquitin chains accumulate following 26S proteasomal dysfunction in mammalian neurones.
Neuroscience letters 2011;491(1):44-7.
2010: N Rogers; S Paine; L Bedford; Robert Layfield
Review: the ubiquitin-proteasome system: contributions to cell death or survival in neurodegeneration.
Neuropathology and applied neurobiology 2010;36(2):113-24.
2010: Sophia A Solomon; Robert Layfield
The coordination chemistry of silyl-substituted allyl ligands.
Dalton transactions (Cambridge, England : 2003) 2010;39(10):2469-83.
2009: Simon Paine; Lynn Bedford; Julian R Thorpe; R John Mayer; James R Cavey; Nin Bajaj; Paul Sheppard; James Lowe; Robert Layfield
Immunoreactivity to Lys63-linked polyubiquitin is a feature of neurodegeneration.
Neuroscience letters 2009;460(3):205-8.
2009: catrin rutland; Louise Warner; Aaran Thorpe; Aziza Alibhai; Thelma Robinson; Barry Shaw; Robert Layfield; J David Brook; Siobhan Loughna
Knockdown of alpha myosin heavy chain disrupts the cytoskeleton and leads to multiple defects during chick cardiogenesis.
Journal of anatomy 2009;214(6):905-15.
2009: Dereen Najat; Thomas Garner; Thilo Hagen; Barry Shaw; Paul Sheppard; Alberto Falchetti; Francesca Marini; Maria L Brandi; Jed E Long; James R Cavey; Mark S Searle; Robert Layfield
Characterization of a non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in Paget's disease of bone.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2009;24(4):632-42.
2009: Andrew J Murton; Nima Alamdari; Sheila M Gardiner; Dumitru Constantin-Teodosiu; Robert Layfield; Terence Bennett; Paul L Greenhaff
Effects of endotoxaemia on protein metabolism in rat fast-twitch skeletal muscle and myocardium.
PloS one 2009;4(9):e6945.
2008: Robert Layfield; R John Mayer
The ubiquitin proteasome system in human disease.
Biochimica et biophysica acta 2008;1782(12):681-2.
2008: Sophia A Solomon; Christopher A Muryn; Robert Layfield
s-Block metal complexes of a bulky, donor-functionalized allyl ligand.
Chemical communications (Cambridge, England) 2008;(27):3142-4.
2008: Robert Layfield
Manganese(II): the black sheep of the organometallic family.
Chemical Society reviews 2008;37(6):1098-107.
2008: Robert Layfield; Mark S Searle
Disruption of ubiquitin-mediated processes in diseases of the brain and bone.
Biochemical Society transactions 2008;36(Pt 3):469-71.
2008: Robert Layfield; Balwir Matharoo-Ball
The 6(th) East Midlands Proteomics Workshop supported by the BSPR and BMSS 14 November 2007, Nottingham, UK.
Proteomics 2008;8(9):1754-5.
2008: Begoña Caneda-Ferrón; Luigi A De Girolamo; Teresa Costa; Katy E Beck; Robert Layfield; E Ellen Billett
Assessment of the direct and indirect effects of MPP+ and dopamine on the human proteasome: implications for Parkinson's disease aetiology.
Journal of neurochemistry 2008;105(1):225-38.
2008: Jed Long; Thomas R A Gallagher; James R Cavey; Paul Sheppard; Stuart H Ralston; Robert Layfield; Mark S Searle
Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switch.
The Journal of biological chemistry 2008;283(9):5427-40.
2007: Robert Layfield; Felipe García; Julien Hannauer; Simon M Humphrey
Ansa-tris(allyl) complexes of alkali metals: tripodal analogues of cyclopentadienyl and ansa-metallocene ligands.
Chemical communications (Cambridge, England) 2007;(47):5081-3.
2007: Despina Constantin; Dumitru Constantin-Teodosiu; Robert Layfield; Kostas Tsintzas; Andrew J Bennett; Paul L Greenhaff
PPARdelta agonism induces a change in fuel metabolism and activation of an atrophy programme, but does not impair mitochondrial function in rat skeletal muscle.
The Journal of physiology 2007;583(Pt 1):381-90.
2007: Balwir Matharoo-Ball; C Hughes; Lee Lancashire; David Tooth; Graham Ball; Colin S Creaser; M Elgasim; Robert Rees; Robert Layfield; William Atiomo
Characterization of biomarkers in polycystic ovary syndrome (PCOS) using multiple distinct proteomic platforms.
Journal of proteome research 2007;6(8):3321-8.
2007: Suebwong Chuthapisith; Robert Layfield; Ian D Kerr; Catherine Hughes; Oleg Eremin
Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs.
International journal of oncology 2007;30(6):1545-51.
2007: Emma Tomlinson; Naaventhan Palaniyappan; David Tooth; Robert Layfield
Methods for the purification of ubiquitinated proteins.
Proteomics 2007;7(7):1016-22.
2007: Andriani Athanasiou; Paul A Smith; Sara Vakilpour; Nethia M Kumaran; Amy E Turner; Dimitra Bagiokou; Robert Layfield; David E Ray; Andrew D Westwell; S P H Alexander; David A Kendall; Dileep N Lobo; Susan A Watson; Artitaya Lophatanon; Kenneth A Muir; De-An Guo; Timothy E Bates
Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: how vanilloids cause non-vanilloid receptor mediated cell death.
Biochemical and biophysical research communications 2007;354(1):50-5.
2007: Suebwong Chuthapisith; Robert Layfield; Ian D Kerr; Oleg Eremin
Principles of proteomics and its applications in cancer.
The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 2007;5(1):14-22.
2007: Robert Layfield; Barry Shaw
Ubiquitin-mediated signalling and Paget's disease of bone.
BMC biochemistry 2007;8 Suppl 1():S5.
2007: Robert Layfield
The molecular pathogenesis of Paget disease of bone.
Expert reviews in molecular medicine 2007;9(27):1-13.
2006: Robert Layfield; James R Cavey; D Najat; J Long; Paul Sheppard; Stuart H Ralston; Mark S Searle
p62 mutations, ubiquitin recognition and Paget's disease of bone.
Biochemical Society transactions 2006;34(Pt 5):735-7.
2006: Catherine Hughes; Mustafa Elgasim; Robert Layfield; William Atiomo
Genomic and post-genomic approaches to polycystic ovary syndrome--progress so far: Mini Review.
Human reproduction (Oxford, England) 2006;21(11):2766-75.
2006: Robert Layfield; Thomas H Bullock; Felipe García; Simon M Humphrey; Peter Schüler
The cationic cluster Grignard [{MgCl(thf)2}3(mu3-C3H5)2]+.
Chemical communications (Cambridge, England) 2006;(19):2039-41.
2006: James R Cavey; Stuart H Ralston; Paul Sheppard; Barbara Ciani; T R A Gallagher; J E Long; Mark S Searle; Robert Layfield
Loss of ubiquitin binding is a unifying mechanism by which mutations of SQSTM1 cause Paget's disease of bone.
Calcified tissue international 2006;78(5):271-7.
2006: Robert Layfield; Alan Bashall; Mary McPartlin; Jeremy M Rawson; Dominic S Wright
A structural and magnetic study of organolanthanide(III) amides.
Dalton transactions (Cambridge, England : 2003) 2006;(13):1660-6.
2006: Carmen Soria Alvarez; Alan Bashall; Eric J L McInnes; Robert Layfield; Richard A Mole; Mary McPartlin; Jeremy M Rawson; Paul T Wood; Dominic S Wright
Structural and magnetic studies of the tris(cyclopentadienyl)manganese(II) "paddle-wheel" anions [Cp(3-n)(MeCp)(n)Mn](-) (n=0-3, MeCp=C(5)H(4)CH(3), Cp=C(5)H(5)).
Chemistry (Weinheim an der Bergstrasse, Germany) 2006;12(11):3053-60.
2005: andrew Hopkinson; Richard S McIntosh; Robert Layfield; John Keyte; Harminder S Dua; Patrick J Tighe
Optimised two-dimensional electrophoresis procedures for the protein characterisation of structural tissues.
Proteomics 2005;5(7):1967-79.
2005: James R Cavey; Stuart H Ralston; Lynne J Hocking; Paul Sheppard; Barbara Ciani; Mark S Searle; Robert Layfield
Loss of ubiquitin-binding associated with Paget's disease of bone p62 (SQSTM1) mutations.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005;20(4):619-24.
2005: Carmen Soria Alvarez; Felipe García; Simon M Humphrey; Alexander D Hopkins; Richard A Kowenicki; Mary McPartlin; Robert Layfield; Robert Raja; Michael C Rogers; Anthony D Woods; Dominic S Wright
Highly selective epoxidation of styrene using a transition metal-aluminium(III) complex containing the [MeAl(2-py)3]- anion (2-py = 2-pyridyl).
Chemical communications (Cambridge, England) 2005;(2):198-200.
2005: Robert Layfield; James Lowe; Lynn Bedford
The ubiquitin-proteasome system and neurodegenerative disorders.
Essays in biochemistry 2005;41():157-71.
2004: Carmen Soria Alvarez; Sally R Boss; Jonathan C Burley; Simon M Humphry; Robert Layfield; Richard A Kowenicki; Mary McPartlin; Jeremy M Rawson; Andrew E H Wheatley; Paul T Wood; Dominic S Wright
Syntheses, structures and magnetic properties of Mn(II) dimers [CpMn(micro-X)]2(Cp = C5H5; X = RNH, R1R2N, C[triple bond]CR).
Dalton transactions (Cambridge, England : 2003) 2004;(21):3481-7.
2004: Robert Layfield; Barbara Ciani; Stuart H Ralston; Lynne J Hocking; Paul Sheppard; Mark S Searle; James R Cavey
Structural and functional studies of mutations affecting the UBA domain of SQSTM1 (p62) which cause Paget's disease of bone.
Biochemical Society transactions 2004;32(Pt 5):728-30.
2004: Robert Layfield; Lynne J Hocking
SQSTM1 and Paget's disease of bone.
Calcified tissue international 2004;75(5):347-57.
2004: Lynne J Hocking; Gavin J A Lucas; Anna Daroszewska; Tim Cundy; Geoffrey C Nicholson; Judit Donath; John P Walsh; Catriona Finlayson; James R Cavey; Barbara Ciani; Paul Sheppard; Mark S Searle; Robert Layfield; Stuart H Ralston
Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2004;19(7):1122-7.
2004: Robert Layfield; Simon M Humphrey
A manganese(II) allyl complex: synthesis, structure, and magnetic properties of [Li(thf)4][Mn[eta3-(Me3Si)2C3H3][eta1-(Me3Si)2C3H3]2].
Angewandte Chemie (International ed. in English) 2004;43(23):3067-9.
2003: Geoffrey W Platt; Stephen A Simpson; Robert Layfield; Mark S Searle
Stability and folding kinetics of a ubiquitin mutant with a strong propensity for nonnative beta-hairpin conformation in the unfolded state.
Biochemistry 2003;42(46):13762-71.
2003: Robert Layfield; James R Cavey; James Lowe
Role of ubiquitin-mediated proteolysis in the pathogenesis of neurodegenerative disorders.
Ageing research reviews 2003;2(4):343-56.
2003: Barbara Ciani; Robert Layfield; James R Cavey; Paul Sheppard; Mark S Searle
Structure of the ubiquitin-associated domain of p62 (SQSTM1) and implications for mutations that cause Paget's disease of bone.
The Journal of biological chemistry 2003;278(39):37409-12.
2003: Dmitriy Alexeev; Paul N Barlow; Stella M Bury; Jean-Damien Charrier; Alan Cooper; David Hadfield; Craig Jamieson; Sharon M Kelly; Robert Layfield; R John Mayer; Helen McSparron; Nicholas C Price; Robert Ramage; Lindsay Sawyer; Bernard A Starkmann; Dusan Uhrin; Jill Wilken; Douglas W Young
Synthesis, structural and biological studies of ubiquitin mutants containing (2S, 4S)-5-fluoroleucine residues strategically placed in the hydrophobic core.
Chembiochem : a European journal of chemical biology 2003;4(9):894-6.
2002: Carmen Soria Alvarez; Andrew D Bond; Dale Cave; Marta E G Mosquera; Eilís A Harron; Robert Layfield; Mary McPartlin; Jeremy M Rawson; Paul T Wood; Dominic S Wright
Syntheses and magnetic properties of hexanuclear [Cp2Mn3(L1)4]2 and octanuclear [Mn8(L2)12(mu 4-O)2] (L1 = 2-HNC5H5N, L2 = 2-NH-3-Br-5-MeC5H3N, Cp = C5H5).
Chemical communications (Cambridge, England) 2002;(24):2980-1.
2002: Della C David; Robert Layfield; Louise C Serpell; Yolanda Narain; Michel Goedert; Maria Grazia Spillantini
Proteasomal degradation of tau protein.
Journal of neurochemistry 2002;83(1):176-85.
2002: Carole A Morrison; Dominic S Wright; Robert Layfield
Interpreting molecular crystal disorder in plumbocene, Pb(C5H5)2: insight from theory.
Journal of the American Chemical Society 2002;124(23):6775-80.
2001: George K Tofaris; Robert Layfield; Maria Grazia Spillantini
alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome.
FEBS letters 2001;509(1):22-6.
2001: Andrew D Bond; Robert Layfield; J A MacAllister; Mary McPartlin; Jeremy M Rawson; Dominic S Wright
The first observation of the [Cp3Mn]- anion; structures of hexagonal [(eta 2-Cp)3MnK.1.5thf] and ion-separated [(eta 2-Cp)3Mn]2[Mg(thf)6].2thf.
Chemical communications (Cambridge, England) 2001;(19):1956-7.
2001: Robert Layfield; David Tooth; M Landon; S Dawson; J Mayer; A Alban
Purification of poly-ubiquitinated proteins by S5a-affinity chromatography.
Proteomics 2001;1(6):773-7.
2001: Robert Layfield; A Alban; R J Mayer; James Lowe
The ubiquitin protein catabolic disorders.
Neuropathology and applied neurobiology 2001;27(3):171-9.
2001: Robert Layfield
Does an inhibition of the ubiquitin/26S proteasome pathway of protein degradation underlie the pathogenesis of non-familial Alzheimer's disease?
Medical hypotheses 2001;56(3):395-9.
2001: James Lowe; J Mayer; M Landon; Robert Layfield
Ubiquitin and the molecular pathology of neurodegenerative diseases.
Advances in experimental medicine and biology 2001;487():169-86.
2000: Y Amy Lam; Cecile M Pickart; A Alban; M Landon; C Jamieson; Robert Ramage; R J Mayer; Robert Layfield
Inhibition of the ubiquitin-proteasome system in Alzheimer's disease.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(18):9902-6.
1999: Robert Layfield; K Franklin; M Landon; G Walker; P Wang; Robert Ramage; A Brown; S Love; K Urquhart; T Muir; R Baker; RJ Mayer
Chemically synthesized ubiquitin extension proteins detect distinct catalytic capacities of deubiquitinating enzymes.
Analytical biochemistry 1999;274(1):40-9.
1999: P Wang; Robert Layfield; M Landon; R John Mayer; Robert Ramage
Selective isopeptide bond formation: coupling ubiquitin(67-76) with histone 2A(114-128) by use of the transfer active ester condensation technique.
The journal of peptide research : official journal of the American Peptide Society 1999;53(6):673-7.
1999: Robert Layfield; C Hayes; P Wang; K Urquhart; Robert Ramage; RJ Mayer; M Landon
Electrophoretic separation of ubiquitin and single amino acid residue ubiquitin extensions using a commercial modified acrylamide gel electrophoresis system: an assay to determine catalytic capacities of deubiquitinating enzymes.
Electrophoresis 1999;20(3):480-2.
1998: RJ Mayer; M Landon; Robert Layfield
Ubiquitin superfolds: intrinsic and attachable regulators of cellular activities?
Folding & design 1998;3(5):R97-9.
1997: Robert Layfield; K Bailey; Robert A Dineen; P Mehrotra; James Lowe; R Allibone; RJ Mayer; M Landon
Application of formalin fixation to the purification of amyloid proteins.
Analytical biochemistry 1997;253(1):142-4.
1997: K Franklin; Robert Layfield; M Landon; Robert Ramage; A Brown; S Love; T Muir; K Urquhart; M Bownes; RJ Mayer
Capillary electrophoresis assay for ubiquitin carboxyl-terminal hydrolases with chemically synthesized ubiquitin-valine as substrate.
Analytical biochemistry 1997;247(2):305-9.
1996: Robert Layfield; K Bailey; J Lowe; R Allibone; R J Mayer; M Landon
Extraction and protein sequencing of immunoglobulin light chain from formalin-fixed cerebrovascular amyloid deposits.
The Journal of pathology 1996;180(4):455-9.
1996: J Fergusson; M Landon; J Lowe; S P Dawson; Robert Layfield; D P Hanger; R J Mayer
Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome.
Neuroscience letters 1996;219(3):167-70.
1996: Robert Layfield; J Fergusson; A Aitken; J Lowe; M Landon; R J Mayer
Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins.
Neuroscience letters 1996;209(1):57-60.